Nature Foods for the Treatment of Nonalcoholic Fatty Liver Disease

被引:2
|
作者
Sun, Mengxia [1 ]
Ye, Hua [1 ,2 ]
机构
[1] Ningbo Univ, Affiliated Lihuili Hosp, Ningbo, Peoples R China
[2] Ningbo Univ, Affiliated Lihuili Hosp, Ningbo 315040, Peoples R China
关键词
mechanism; NAFLD; nature food; therapy; DIET-INDUCED OBESITY; LYCIUM-BARBARUM; HEPATIC STEATOSIS; CHLOROGENIC ACID; OXIDATIVE STRESS; GENE-EXPRESSION; LIPID PROFILE; DOUBLE-BLIND; HEPG2; CELLS; PPAR-GAMMA;
D O I
10.1089/jmf.2022.K.0052
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. The etiology of NAFLD is highly heterogeneous, which occurs and develops under the joint action of metabolism, inflammation, genetics, environment, and gut microbiota. At present, the principal therapeutic modalities targeting NAFLD are lifestyle interventions such as weight loss through diet and exercise. At present, there is no established therapy for the treatment of NAFLD, and many therapies are associated with a variety of side effects. A great number of in vitro and in vivo experiments have indicated that there are many natural foods that have therapeutic potential for NAFLD. This review summarizes the natural foods and their mechanisms that were found in recent years, furthermore, provides further information relevant to the treatment of NAFLD.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [41] Current best treatment for nonalcoholic fatty liver disease
    Angulo, P
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (05) : 611 - 623
  • [42] The pharmacological treatment of nonalcoholic fatty liver disease in children
    Crudele, Annalisa
    Panera, Nadia
    Braghini, Maria Rita
    Balsano, Clara
    Alisi, Anna
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (11) : 1219 - 1227
  • [43] Nonalcoholic Fatty Liver Disease Is Related to Nonalcoholic Fatty Pancreas Disease
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C. M. A.
    van der Peet, Donald L.
    Bloemena, Elisabeth
    Mulder, Chris J. J.
    PANCREAS, 2010, 39 (08) : 1185 - 1190
  • [44] Features, Diagnosis, and Treatment of Nonalcoholic Fatty Liver Disease
    Torres, Dawn M.
    Williams, Christopher D.
    HarrisonO, Stephen A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (08) : 837 - 858
  • [45] Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
    Imajo, Kento
    Yoneda, Masato
    Kessoku, Takaomi
    Ogawa, Yuji
    Maeda, Shin
    Sumida, Yoshio
    Hyogo, Hideyuki
    Eguchi, Yuichiro
    Wada, Koichiro
    Nakajima, Atsushi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (11) : 21833 - 21857
  • [46] Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease
    Nseir, W.
    Shalata, A.
    Marmor, A.
    Assy, N.
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (12) : 3439 - 3449
  • [47] Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of α-tocopherol (vitamin E)
    Bartolini, Desiree
    Torquato, Pierangelo
    Barola, Carolina
    Russo, Angelo
    Rychlicki, Chiara
    Giusepponi, Danilo
    Bellezza, Guido
    Sidoni, Angelo
    Galarini, Roberta
    Svegliati-Baroni, Gianluca
    Galli, Francesco
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2017, 47 : 120 - 131
  • [48] Potential Biological Effects of (-)-Epigallocatechin-3-gallate on the Treatment of Nonalcoholic Fatty Liver Disease
    Chen, Cheng
    Liu, Qian
    Liu, Lin
    Hu, Yi-yang
    Feng, Qin
    MOLECULAR NUTRITION & FOOD RESEARCH, 2018, 62 (01)
  • [49] Aberrant Hepatic MicroRNA Expression in Nonalcoholic Fatty Liver Disease
    Feng, Yue Ying
    Xu, Xiao Qin
    Ji, Chen Bo
    Shi, Chun Mei
    Guo, Xi Rong
    Fu, Jun Fen
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2014, 34 (06) : 1983 - 1997
  • [50] Nonalcoholic Fatty Liver Disease
    Wang, Xiao Jing
    Malhi, Harmeet
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (09) : ITC65 - ITC80